Slate Path Capital’s Ironwood Pharmaceuticals IRWD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
Sell
-2,640,000
Closed -$27.2M 31
2020
Q2
$27.2M Buy
2,640,000
+1,300,000
+97% +$13.4M 1.61% 14
2020
Q1
$13.5M Buy
+1,340,000
New +$13.5M 1.04% 13